{
    "organizations": [],
    "uuid": "e8e76b2f50f434a1eadc3f0b0546a7e015527b23",
    "author": "",
    "url": "https://www.reuters.com/article/brief-nymox-announces-1625-million-equit/brief-nymox-announces-16-25-million-equity-financing-idUSASC09VPO",
    "ord_in_thread": 0,
    "title": "BRIEF-Nymox Announces $16.25 Million Equity Financing",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 12 (Reuters) - Nymox Pharmaceutical Corp:\n* NYMOX ANNOUNCES $16.25 MILLION EQUITY FINANCING WITH QUALIFIED LONG-TERM INVESTORS\n* WITH NEW FUNDS, TO BE FINANCED BEYOND EXPECTED OUTCOME TIMINGS FOR REGULATORY SUBMISSIONS IN EUROPE & U.S. FOR FEXAPOTIDE TRIFLUTATE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-12T17:28:00.000+03:00",
    "crawled": "2018-04-12T17:34:32.028+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "nymox",
        "pharmaceutical",
        "corp",
        "nymox",
        "announces",
        "million",
        "equity",
        "financing",
        "qualified",
        "investor",
        "new",
        "fund",
        "financed",
        "beyond",
        "expected",
        "outcome",
        "timing",
        "regulatory",
        "submission",
        "europe",
        "fexapotide",
        "triflutate",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}